IDiyas

For the Inventor, By the Inventor

Scotch Plains, NJ, United States of America

Richard John Varsolona

USPTO Granted Patents = 25 



Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 92(Granted Patents)


Company Filing History:

goldMedal13 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal6 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal5 out of 1,535 
 
Boehringer Ingelheim International Gmbh
 patents
4. 1 out of 245 
 
Intervet Inc.
 patents
5. 1 out of 276 
 
Boehringer Ingelheim Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents
1. 12391694 - Process for the preparation of 2-fluoroadenine (2025-08-19),
2. 12018020 - Crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide (2024-06-25),
3. 11542279 - Solid forms of ceftolozane and processes for preparing (2023-01-03),
4. 11306080 - Crystalline form of a BACE inhibitor, compositions, and use (2022-04-19),
5. 10457690 - Process for preparing substituted tetracyclic heterocycle compounds (2019-10-29),
6. 10017505 - Crystalline forms of a BACE inhibitor, compositions, and their use (2018-07-10),
7. 9873707 - Methods and intermediates for preparing macrolactams (2018-01-23),
8. 8598183 - Solid state forms of a potent HCV inhibitor (2013-12-03),
9. 8362035 - Crystalline forms of a potent HCV inhibitor (2013-01-29),
10. 8232293 - Crystalline forms of a potent HCV inhibitor (2012-07-31),
11. 7470795 - Synthesis of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides (2008-12-30),
12. 7309700 - Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e] [1,4]diazepin-6-one (2007-12-18),
13. 6642237 - Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof (2003-11-04),
14. 6486195 - Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation (2002-11-26),
15. 6071916 - HIV protease inhibitor (2000-06-06),

Sure, I can help you with that. Let's start with the article about inventor Richard John Varsolona.

Title: The Innovative Legacy of Richard John Varsolona

Introduction:

Richard John Varsolona is a prolific inventor based in Scotch Plains, NJ (US) with an impressive track record in the field of pharmaceuticals. His dedication to innovation and research has led to the development of numerous groundbreaking patents.

Latest Patents:

Richard John Varsolona's latest patents showcase his expertise in the pharmaceutical industry. One of his innovations includes the development of a novel solid form of ceftolozane sulfate, offering new possibilities for drug synthesis and composition. Additionally, his work on a crystalline form of a BACE inhibitor shows promise in the treatment of Alzheimer's disease and related cognitive impairments.

Career Highlights:

Throughout his career, Richard John Varsolona has made significant contributions to companies like Merck & Company, Inc. and Boehringer Ingelheim International GmbH. His innovative spirit and commitment to scientific advancements have earned him recognition as a leading figure in the field of pharmaceutical research.

Collaborations:

In his professional journey, Richard John Varsolona has collaborated with esteemed colleagues such as David Askin and Paul J. Reider. Together, they have worked on cutting-edge projects that have pushed the boundaries of pharmaceutical innovation.

Conclusion:

In conclusion, Richard John Varsolona's impact on the world of pharmaceuticals cannot be understated. His groundbreaking patents and collaborations stand as a testament to his unwavering dedication to advancing science and improving healthcare outcomes. Richard John Varsolona's legacy as an inventor continues to inspire future generations of innovators in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…